Stay updated with breaking news from Fibroid symptom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Elagolix sodium, an oral short-acting nonpeptide gonadotropin-releasing hormone antagonist has been approved by the FDA at a dose of 300 mg twice daily with add-back therapy for up to 24 months. ....